OCUL - Company ID 0001393434
OCULAR THERAPEUTIX, INC (OCUL) reported net income of -$265.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$265.94M | -37.4% |
| FY 2024 | -$193.51M | -139.7% |
| FY 2023 | -$80.74M | -13.7% |
| FY 2022 | -$71.04M | -984.1% |
| FY 2021 | -$6.55M | +95.8% |
| FY 2020 | -$155.64M | -80.2% |
| FY 2019 | -$86.37M | -44.0% |
| FY 2018 | -$59.98M | +5.4% |
| FY 2017 |
OCULAR THERAPEUTIX, INC (OCUL) reported net income of -$265.94M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2012 and fiscal 2025, OCULAR THERAPEUTIX, INC's net income declined from -$14.09M to -$265.94M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$63.39M |
| -41.8% |
| FY 2016 | -$44.70M | -12.5% |
| FY 2015 | -$39.75M | -38.7% |
| FY 2014 | -$28.65M | -115.1% |
| FY 2013 | -$13.32M | +5.5% |
| FY 2012 | -$14.09M | - |